Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sanofi-Aventis S.A. ADR (SNY)

Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
REGN Q3 Earnings and Revenues Beat on Strong Eylea HD & Dupixent Sales

Regeneron Pharmaceuticals, Inc. REGN reported better-than-expected third-quarter results despite lower sales from its lead drug, Eylea. Revenues climbed 11% to $3.72 billion, driven by growth in Eylea...

BAYRY : 6.7600 (-0.59%)
NVS : 110.52 (+1.07%)
REGN : 828.84 (-1.75%)
SNY : 52.95 (-0.60%)
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split

One of these players has split its stock in the past. The other one hasn't.

NVDA : 136.05 (+0.48%)
LLY : 806.14 (-1.56%)
GS : 511.47 (-1.52%)
CMG : 56.38 (-3.77%)
REGN : 828.84 (-1.75%)
AMGN : 316.91 (-0.72%)
WMT : 82.45 (+0.32%)
SNY : 52.95 (-0.60%)
Why Sanofi Stock Flew Higher on Friday

No investor can ignore a crushing bottom-line beat and raised profitability guidance.

SNY : 52.95 (-0.60%)
Pharma Stock Roundup: RHHBY Earnings, Drug Pipeline & Regulatory News

This week, Roche RHHBY announced its third-quarter and nine-month results. Sanofi SNY confirmed that it is holding exclusive talks with U.S. private equity company CD&R to sell a controlling stake in its...

AZN : 71.43 (+0.01%)
NVO : 109.72 (-1.98%)
RHHBY : 39.4300 (+0.43%)
PFE : 27.76 (-1.17%)
SNY : 52.95 (-0.60%)
Sanofi (SNY) Q3 2024 Earnings Call Transcript

SNY earnings call for the period ending September 30, 2024.

SNY : 52.95 (-0.60%)
Sanofi Q3 Earnings Beat, Dupixent, New Drugs, Vaccines Drive Sales

Sanofi SNY reported third-quarter 2024 adjusted earnings of $1.57 per American depositary share, which beat the Zacks Consensus Estimate of $1.35 per share. Earnings of €2.86 per share rose 12.2% on...

AZN : 71.43 (+0.01%)
LLY : 806.14 (-1.56%)
REGN : 828.84 (-1.75%)
SNY : 52.95 (-0.60%)
The Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi

For Immediate ReleaseChicago, IL – October 22, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...

JNJ : 158.24 (-1.18%)
ABBV : 200.47 (-1.51%)
RHHBY : 39.4300 (+0.43%)
PFE : 27.76 (-1.17%)
SNY : 52.95 (-0.60%)
Sanofi Negotiating Exclusively With CD&R for Opella 50% Stake Sale

Sanofi SNY has entered into exclusive negotiations with U.S.-based private equity company Clayton Dubilier & Rice (CD&R) for the potential sale of a 50% controlling stake in its consumer healthcare (CHC)...

JNJ : 158.24 (-1.18%)
GSK : 36.97 (+0.24%)
PFE : 27.76 (-1.17%)
SNY : 52.95 (-0.60%)
This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?

Let's look beyond this piece of bad news from regulators.

NVAX : 9.12 (-2.46%)
SNY : 52.95 (-0.60%)
Pharma Stock Roundup: JNJ's Q3 Earnings, FDA Nod to Some New Drugs

This week, Johnson & Johnson JNJ began the third-quarter earnings season for the drug and biotech sector. The FDA granted approval to a few new drugs, which included Pfizer’s PFE gene therapy for hemophilia,...

JNJ : 158.24 (-1.18%)
ABBV : 200.47 (-1.51%)
RHHBY : 39.4300 (+0.43%)
PFE : 27.76 (-1.17%)
SNY : 52.95 (-0.60%)

Barchart Exclusives

Unlock Higher Returns with this Netflix Option Trade
With Netflix stock trading around $755, setting up a calendar spread at $755 gives the trade a neutral outlook. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar